Pfizer: RSV vaccine launched in Canada
The vaccine becomes the only RSV vaccine available in Canada for the active immunization of pregnant women between the 32nd and 36th weeks of pregnancy, to prevent lower respiratory tract disease in infants from birth to six months of age.
Last December, Health Canada - the Canadian health authority - approved the vaccine for the prevention of both severe and mild lower respiratory tract illnesses caused by RSV.
Copyright (c) 2024 CercleFinance.com. All rights reserved.
Go to the original article.
Contact us to request a correction